167 related articles for article (PubMed ID: 1263111)
1. Physiological disposition and biotransformation of (3H) cocaine in acutely and chronically treated rats.
Nayak PK; Misra AL; Mulé SJ
J Pharmacol Exp Ther; 1976 Mar; 196(3):556-69. PubMed ID: 1263111
[TBL] [Abstract][Full Text] [Related]
2. Disposition and metabolism of [3H]cocaine in acutely and chronically treated dogs.
Misra AL; Patel MN; Alluri VR; Mulé SJ; Nayak PK
Xenobiotica; 1976 Sep; 6(9):537-52. PubMed ID: 983124
[TBL] [Abstract][Full Text] [Related]
3. Physiological disposition and biotransformation of [allyl-1', 3' - 14C naloxone in the rat and some comparative observations on nalorphine.
Misra AL; Pontani RB; Vadlamani NL; Mulé SJ
J Pharmacol Exp Ther; 1976 Feb; 196(2):257-68. PubMed ID: 1255476
[TBL] [Abstract][Full Text] [Related]
4. Influence of acid or alkaline treatment on tissue distribution and urinary excretion of (3H)-cocaine on acutely treated rats.
Lallemant AM; Thevenin M
Clin Toxicol; 1980 Apr; 16(2):135-48. PubMed ID: 6249533
[TBL] [Abstract][Full Text] [Related]
5. Disposition of (3H) benzoylnorecgonine (cocaine metabolite) in the rat.
Misra AL; Giri VV; Patel MN; Alluri VR; Pontani RB; Mule SJ
Res Commun Chem Pathol Pharmacol; 1976 Apr; 13(4):579-84. PubMed ID: 1265338
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of norcocaine, N-hydroxy norcocaine and cocaine-N-oxide in the rat.
Misra AL; Pontani RB; Vadlamani NL
Xenobiotica; 1979 Mar; 9(3):189-99. PubMed ID: 473794
[TBL] [Abstract][Full Text] [Related]
7. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
8. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and disposition of trifluoperazine in the rat. II. Kinetics after oral and intravenous administration in acutely and chronically treated animals.
Schmalzing G
Drug Metab Dispos; 1977; 5(2):104-15. PubMed ID: 15802
[TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
12. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J
Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
15. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
16. Disposition and metabolism of [14C]-haloperidol in rats.
Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
[TBL] [Abstract][Full Text] [Related]
17. Metabolism, disposition, and pharmacokinetics of a potent anticonvulsant, 4-amino-N-(2,6-dimethylphenyl)benzamide (LY201116), in rats.
Potts BD; Gabriel S; Parli CJ
Drug Metab Dispos; 1989; 17(6):656-61. PubMed ID: 2575503
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
[TBL] [Abstract][Full Text] [Related]
19. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
20. Disposition of (15,16-3H)naltrexone in the central nervous system of the rat.
Misra AL; Bloch R; Vardy J; Mulé SJ; Verebely K
Drug Metab Dispos; 1976; 4(3):276-80. PubMed ID: 6233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
